Vanderbilt University

The drug is also approved for the treatment of systemic anaplastic large cell lymphoma (sALCL) after failure of at least one prior multi-agent chemotherapy regimen. Efficacy was shown in phase II open-label, single-arm, multi-center studies for both HL and sALCL. ................
................